Bristol Myers Squibb (BMY) Stock Price & AI Analysis

NYSE
USA

$59.38

$1
(1.49%)

Subscribe to get
AI Score

Bristol Myers Squibb Company Profile

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol Myers Squibb | Latest news

Bristol-Myers Squibb Company (BMY): Close to Becoming a Dividend Aristocrat

We recently published a list of 10 Stocks That Are Close To Becoming Dividend Aristocrats. In this...

Insider Monkey - 5 days ago

... On 3 Health Care Stocks With Over 4% Dividend Yields - AbbVie (NYSE:ABBV),...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health...

Benzinga - 5 days ago

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is...

Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it...

Zacks - 5 days ago

CFRA cuts Bristol-Myers to hold; sees limited upside By Investing.com

On Tuesday, CFRA downgraded shares of Bristol-Myers Squibb Co. (NYSE:BMY) from Buy to Hold,...

Investingcom - 4 days ago

Is Bristol-Myers Squibb Stock a Millionaire Maker?

Bristol-Myers Squibb (NYSE: BMY) is the kind of stock that potentially has a lot to offer to investors looking for wealth-building investments. With that...

Motley Fool - 6 days ago

Our newest portfolio stock backed off its recent 52-week high — so we're buying...

Following Wednesday's trade, Jim Cramer's Charitable Trust will own 800 shares of BMY, increasing its weighting to about 1.25% from 1%. Shares of pharmaceutical maker Bristol-Myers have dropped ...

CNBC - 4 days ago

2 Simple ETFs to Buy With $1,000 and Hold for a Lifetime

Company Name Symbol Percentage of Holdings BlackRock BLK 4.5% Bristol Myers Squibb BMY 4.5% Cisco...

Motley Fool - 1 day ago

Exclusive-Big hedge funds call on doctors, scientists for an edge on pharma,...

Abbvie shares opened 11% lower on Nov. 11 after the company announced its mid-stage schizophrenia...

Investingcom - 4 days ago

PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy

Shares of PPBT surged 150.4% on Monday in response to the news. The phase II study evaluated CM24 in...

Zacks - 5 days ago

Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report?

Free Report) . Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important ...

Zacks - 4 days ago